Industry News
NICE recommendation set to leave UK patients with newly diagnosed advanced melanoma without access to Yervoy®q (ipilimumab)
Feb 26, 2014
Bristol-Myers Squibb has expressed its disappointment that the National Institute for Health and Care Excellence (NICE) has issued draft guidance which effectively denies access to Yervoy®q (ipilimumab) for NHS patients with previously-untreated advanced (unresectable or metastatic) melanoma, not involved in clinical trials. Read More
Scientists explore promising new option for first line of attack in lymphoma
Feb 26, 2014
A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma.Follicular lymphoma is a type of non-Hodgkin's lymphoma, a blood cancer, that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage. Read More
Novel blood screen reveals the risk of dying among healthy people
Feb 26, 2014
A new screening technology reveals a signature of mortality in blood samples. Researchers have identified four biomarkers that help to identify people at high risk of dying from any disease within the next five years.Researchers from Finland and Estonia have discovered novel biological markers that are strongly indicative of risk of dying from any disease within the near future. Read More
Blood transfusion for patients undergoing PCI associated with increased risk of in-hospital cardiac event
Feb 26, 2014
In an analysis that included more than two million patients who underwent a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), there was considerable variation in red blood cell transfusion practices among hospitals across the U.S. Read More
Fast and effective mechanism devised to combat ovarian cancer
Feb 26, 2014
Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.Now Prof. Read More
Scientists discover how Tc toxins inject bacterial toxins
Feb 26, 2014
Bacteria have developed many different ways of smuggling their toxic cargo into cells. Tripartite Tc toxin complexes, which are used by bacteria like the plague pathogen Yersinia pestis and the insect pathogen Photorhabdus luminescens, are particularly unusual. Read More
Pancreatic and other cancers best treated with personalized medicine
Feb 26, 2014
If a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. Read More
Iinappropriate use of high-cost advanced imaging procedures fueled by patients seeking info from sources other than health care providers
Feb 26, 2014
The increasing use of expensive medical imaging procedures in the U.S., like positron emission tomography (PET) scans, is being driven, in part, by patient decisions made after obtaining information from lay media and non-experts, and not from health care providers. Read More
Late diagnosis of cancer a greater risk for uninsured adolescents and young adults
Feb 26, 2014
Study shows way forward for age group that has benefited least from cancer progressA new American Cancer Society study shows that uninsured adolescents and young adults were far more likely to be diagnosed with late-stage cancer, which is more difficult and expensive to treat and more deadly, compared to young patients with health insurance. Read More
Optical device uses light to quickly and easily measure blood's clotting properties
Feb 26, 2014
Defective blood coagulation is one of the leading causes of preventable death in patients who have suffered trauma or undergone surgery. The body's natural defense against severe blood loss is the clotting process, in which platelets, plasma proteins, and other blood components interact to form a sticky, mesh-like structure. But often things go wrong, and blood coagulates too little or too much. Read More
Previous Page Next Page